M&A Deal Summary

Friulia Acquires BMG Pharma

On May 29, 2022, Friulia acquired life science company BMG Pharma for 2M EUR

Acquisition Highlights
  • This is Friulia’s 1st transaction in the Life Science sector.
  • This is Friulia’s largest (disclosed) transaction.
  • This is Friulia’s 1st transaction in Italy.

M&A Deal Summary
Date 2022-05-29
Target BMG Pharma
Sector Life Science
Buyer(s) Friulia
Deal Type Add-on Acquisition
Deal Value 2M EUR

Target

BMG Pharma

Milan, Italy
BMG Pharma is a B2B biopharmaceutical company committed to innovating in the development, registration, and licensing of cutting-edge medical devices and operates in three main therapeutic areas: oral cavity care, osteoarthritis, and aesthetic dermatology. BMG Pharma is based in Milan, Italy.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Friulia

Trieste, Italy
Category Company
Sector Financial Services
DESCRIPTION

Friulia is a regional financial company that promotes the economic development of Friuli Venezia Giulia. Friulia is based in Trieste, Italy.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Italy) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal